BENATI, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 6.434
EU - Europa 2.649
AS - Asia 2.496
SA - Sud America 407
Continente sconosciuto - Info sul continente non disponibili 114
AF - Africa 66
OC - Oceania 31
Totale 12.197
Nazione #
US - Stati Uniti d'America 6.252
IT - Italia 911
SG - Singapore 716
CN - Cina 631
GB - Regno Unito 596
HK - Hong Kong 334
BR - Brasile 299
VN - Vietnam 276
SE - Svezia 214
DE - Germania 196
BD - Bangladesh 165
FR - Francia 145
RU - Federazione Russa 126
FI - Finlandia 95
UA - Ucraina 95
CA - Canada 92
KR - Corea 75
NL - Olanda 68
IN - India 57
ID - Indonesia 37
AR - Argentina 33
BG - Bulgaria 33
JP - Giappone 32
TR - Turchia 32
AU - Australia 31
MX - Messico 30
IQ - Iraq 26
IE - Irlanda 24
BE - Belgio 23
ZA - Sudafrica 21
ES - Italia 17
CH - Svizzera 16
CO - Colombia 16
LT - Lituania 16
EC - Ecuador 15
CR - Costa Rica 14
PK - Pakistan 14
AT - Austria 13
VE - Venezuela 13
AE - Emirati Arabi Uniti 12
CZ - Repubblica Ceca 12
TN - Tunisia 12
MY - Malesia 11
NP - Nepal 11
CL - Cile 10
JO - Giordania 10
MA - Marocco 10
PL - Polonia 9
SA - Arabia Saudita 9
GT - Guatemala 8
AL - Albania 7
DK - Danimarca 7
NI - Nicaragua 7
PH - Filippine 7
PY - Paraguay 7
UY - Uruguay 7
DZ - Algeria 6
IL - Israele 6
IR - Iran 5
JM - Giamaica 5
KE - Kenya 5
PE - Perù 5
SV - El Salvador 5
TW - Taiwan 5
BY - Bielorussia 4
PR - Porto Rico 4
TH - Thailandia 4
BZ - Belize 3
EG - Egitto 3
ET - Etiopia 3
GR - Grecia 3
HN - Honduras 3
KZ - Kazakistan 3
LV - Lettonia 3
PT - Portogallo 3
QA - Qatar 3
RO - Romania 3
RS - Serbia 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GP - Guadalupe 2
HR - Croazia 2
LK - Sri Lanka 2
MD - Moldavia 2
NG - Nigeria 2
PA - Panama 2
PS - Palestinian Territory 2
TT - Trinidad e Tobago 2
AG - Antigua e Barbuda 1
AW - Aruba 1
BW - Botswana 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
EU - Europa 1
HU - Ungheria 1
KG - Kirghizistan 1
LB - Libano 1
Totale 12.078
Città #
Ashburn 863
Santa Clara 575
San Jose 568
Singapore 494
Fairfield 473
Southend 362
Hong Kong 323
Chandler 261
Woodbridge 217
Houston 202
Council Bluffs 191
Seattle 174
Wilmington 167
Nyköping 164
Cambridge 158
Hefei 156
Dearborn 148
Jacksonville 147
Beijing 132
London 114
Bologna 110
Ho Chi Minh City 90
Ann Arbor 89
Helsinki 87
Los Angeles 86
New York 85
Modena 76
The Dalles 73
Milan 67
Seoul 61
Chicago 54
Hanoi 53
San Diego 53
Lauterbourg 41
Princeton 40
Columbus 37
Dallas 36
Orem 35
Sofia 33
São Paulo 32
Eugene 31
Moscow 31
Munich 30
Rome 30
Buffalo 29
Shanghai 28
Jakarta 26
Toronto 26
Parma 22
Tokyo 22
Brussels 21
Atlanta 20
Falls Church 20
Phoenix 20
Queens 19
Boardman 18
Izmir 18
Naples 18
Paris 18
Dublin 17
Redondo Beach 17
Bremen 16
Salt Lake City 16
Tampa 15
Amsterdam 14
Haiphong 14
Montreal 14
Nuremberg 14
Redwood City 14
San Francisco 14
Da Nang 13
Portsmouth 13
Reggio Emilia 13
Boston 12
Brooklyn 12
Turin 12
Adelaide 11
Mexico City 11
Newark 11
Rio de Janeiro 11
Chennai 10
Guangzhou 10
Palermo 10
Wuhan 10
Amman 9
Brno 9
Elk Grove Village 9
Hải Dương 9
Johannesburg 9
Miano 9
Mumbai 9
Piacenza 9
Stockholm 9
Vienna 9
Brasília 8
Denver 8
Des Moines 8
Dong Ket 8
Napoli 8
Padua 8
Totale 8.036
Nome #
In vivo editing of the human mutant Rhodopsin gene by electroporation of plasmid-based CRISPR/Cas9 in the mouse retina 470
CRISPR/Cas9-Mediated In Situ Correction of LAMB3 Gene in Keratinocytes Derived from a Junctional Epidermolysis Bullosa Patient 466
CRISPR/Cas9-mediated specific knock-down of dominant mutations in Rhodopsin gene 433
CRISPR/Cas9 gene editing in vitro and in retinal cells in vivo 415
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 355
In vitro and in vivo CRISPR/Cas9-mediated genome editing to downregulate dominant mutations in Rhodopsin gene 331
An efficient in vitro transposition method by a transcriptionally regulated sleeping beauty system packaged into an integration defective lentiviral vector 312
CD4+ T cell-mediated HLA class II cross-restriction in HIV controllers 311
Altered Responses to Homeostatic Cytokines in Patients with Idiopathic CD4 Lymphocytopenia 307
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 302
DNA vaccination by electroporation amplifies broadly cross-restricted public TCR clonotypes shared with HIV Controllers 289
Comparison of the antigen sensitivity of Gag-specific CD4+ T cell responses in controlled HIV infection and HIV vaccination 289
The shc family protein adaptor, Rai, negatively regulates T cell antigen receptor signaling by inhibiting ZAP-70 recruitment and activation 282
CRISPR-mediated T cell engineering against Non-Small Cell Lung Cancer 275
Allele-specific editing ameliorates dominant retinitis pigmentosa in a transgenic mouse model 274
A High Frequency of HIV-Specific Circulating Follicular Helper T Cells Is Associated with Preserved Memory B Cell Responses in HIV Controllers 271
Gene editing prospects for treating inherited retinal diseases 271
Immunotherapy: ANTI-GD2 CAR T CELLS AGAINST SMALL CELL LUNG CANCER 266
CRISPR/Cas9 Allele-Specific Design To Inactivate A Dominant-Negative Mutation In COL6A1 Causing Ullrich Muscular Dystrophy 260
Engineered Sleeping Beauty Transposon as Efficient System to Optimize Chimp Adenoviral Production 249
Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases 246
HIV controllers maintain a population of highly efficient Th1 effector cells in contrast to patients treated in the long term 243
MHC Class II Tetramer Labeling of Human Primary CD4+ T Cells from HIV Infected Patients 241
Simvastatin impairs humoral and cell-mediated immunity in mice by inhibiting lymphocyte homing, T-cell activation and antigen cross-presentation 235
Public T cell receptors confer high-avidity CD4 responses to HIV controllers 235
The strepsipteran endoparasite Xenos vesparum alters the immunocompetence of its host, the paper wasp Polistes dominulus 230
T cell receptors from the HIV-specific repertoire, means for their production and therapeutic uses thereof 227
Frequent sharing of high-affinity TCRs in naturally controlled HIV infection: implications for vaccination 226
Bcr-Abl stabilizes β-catenin in chronic myeloid leukemia through its tyrosine phosphorylation 220
Characterization of high avidity CD4+ T cells in HIV Controllers 216
Molecular characterization of high avidity CD4+ T cells in HIV Controllers 215
SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of β-catenin and its nuclear signaling 215
Specific cTfh frequency correlates with memory B cell responses in HIV controllers. 214
Opposite effects of simvastatin on the bactericidal and inflammatory response of macrophages to opsonized S. aureus 213
SRC family kinases as potential therapeutic targets for malignancies and immunological disorders 202
Efficient CRISPR/Cas9-Mediated iIn Situ Correction of LAMB3 Gene in Keratinocytes Derived from Junctional Epidermolysis Bullosa Patient 198
CRISPR-Mediated Genome Editing to Redirect T Cells against Non-Small Cell Lung Cancer 197
CRISPR/Cas9 allele-specifc design to inactivate a dominant-negative mutation in COL6A1 causing Ullrich muscular dystrophy. 194
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 191
Public TCRs confer high-avidity CD4 responses to HIV controllers 189
HIV Controller CD4+ T cells preferentially express a public TCR clonotype that confers high avidity responses against Gag 182
In vitro and in vivo genome editing of the RHO gene to downregulate dominant mutations 174
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 172
Induced Pluripotent Stem Cells and Genome-Editing Tools in Determining Gene Function and Therapy for Inherited Retinal Disorders 171
Specific Knock-down of P347S Dominant Mutation in Rhodopsin Gene by CRISPR/Cas9 System 165
Restored Collagen VI Microfilaments Network in the Extracellular Matrix of CRISPR-Edited Ullrich Congenital Muscular Dystrophy Fibroblasts 164
Specific knock-down of C-terminal dominant mutation in Rhodopsin gene by CRISPR/Cas9 system 155
Erratum: Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases (European Journal of Immunology (2006) vol. 36 (11) 10.1002/eji.200636567)) 147
Profibrotic Molecules Are Reduced in CRISPR-Edited Emery–Dreifuss Muscular Dystrophy Fibroblasts 92
Totale 12.197
Categoria #
all - tutte 46.761
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.761


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022591 0 0 0 23 42 47 55 40 85 59 148 92
2022/20231.005 108 102 98 87 123 115 29 69 125 19 64 66
2023/2024671 32 53 55 64 94 30 48 85 20 32 59 99
2024/20252.027 64 40 76 121 373 315 169 127 215 130 173 224
2025/20263.568 238 103 260 419 523 236 432 157 380 313 266 241
2026/20271.408 120 302 536 450 0 0 0 0 0 0 0 0
Totale 12.197